---
title: "Citrine Global Corp. | 10-Q: FY2025 Q3 Revenue: USD 0"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/266616370.md"
datetime: "2025-11-19T21:03:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266616370.md)
  - [en](https://longbridge.com/en/news/266616370.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266616370.md)
---

# Citrine Global Corp. | 10-Q: FY2025 Q3 Revenue: USD 0

Revenue: As of FY2025 Q3, the actual value is USD 0.

EPS: As of FY2025 Q3, the actual value is USD 0.

### Segment Revenue

-   The company did not generate any revenues from product sales as of September 30, 2025.

### Operational Metrics

-   **Net Loss**: For the three months ending September 30, 2025, the net loss was $385,000 compared to $380,000 for the same period in 2024.
-   **Operating Loss**: For the nine months ending September 30, 2025, the operating loss was $832,000 compared to $930,000 for the same period in 2024.
-   **Research and Development Expenses**: For the nine months ending September 30, 2025, research and development expenses were $209,000, compared to $0 for the same period in 2024.
-   **Marketing, General and Administrative Expenses**: For the nine months ending September 30, 2025, these expenses were $623,000 compared to $930,000 for the same period in 2024.

### Cash Flow

-   **Net Cash Used in Operating Activities**: For the nine months ending September 30, 2025, net cash used in operating activities was $227,000 compared to $30,000 for the same period in 2024.
-   **Net Cash Used in Investment Activities**: For the nine months ending September 30, 2025, net cash used in investment activities was $114,000, with no cash used in investment activities for the same period in 2024.
-   **Net Cash Provided by Financing Activities**: For the nine months ending September 30, 2025, net cash provided by financing activities was $342,000 compared to $23,000 for the same period in 2024.

### Unique Metrics

-   **Equity Interest**: The company holds a 69.5% equity interest in SkyTech Orion Ltd. and a 100% equity interest in CTGL Citrine Global Israel Ltd.

### Future Outlook and Strategy

-   **Core Business Focus**: The company is focusing on transforming its operations to align with the global defense, unmanned systems, and advanced drone markets, with plans to establish production centers in Israel and the United States.
-   **Non-Core Business**: The company retains ownership of wellness-related assets, including equity stakes in iBOT and MyPlant, and continues to assess how these assets can be leveraged in the future.
-   **Priority**: The company is leading a strategic capital raise to support international expansion, broaden production capabilities, and prepare for an uplist to the NASDAQ stock exchange.

### Related Stocks

- [CTGL.US](https://longbridge.com/en/quote/CTGL.US.md)

## Related News & Research

- [SkyTech Orion delays Q2 10-Q filing on financial statement preparation delays](https://longbridge.com/en/news/295955771.md)
- [3 Low-Cost ETFs For Investors Seeking to Check Out Walmart Ahead of Q2 Earnings – GXPS, FSTA,TRUO.](https://longbridge.com/en/news/296381462.md)
- [Interactive Brokers Is Holding $930 Billion of Customer Money. Here's What That Earns at Today's Rates.](https://longbridge.com/en/news/296319893.md)
- [Why Are Nebius Shares Trading Lower On Wednesday?](https://longbridge.com/en/news/296383504.md)
- [PPS&V Asset Management Consultants Inc. Has $7.63 Million Position in Apple Inc. $AAPL](https://longbridge.com/en/news/296327659.md)